David A. Ford's most recent trade in Prothena Corporation plc was a trade of 107,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Prothena Corporation plc | David A. Ford | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 107,500 | 107,500 | - | - | Stock Option (Right to Buy) | |
Prothena Corporation plc | David A. Ford | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 16,000 | 16,000 | - | - | Option to Purchase Common Stock | |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 9,800 | 36,438 (0%) | 0% | 0 | Common Stock | |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. | 31 Dec 2022 | 1,777 | 26,638 (0%) | 0% | 12.4 | 21,981 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 11,300 | 11,300 | - | - | Option to Purchase Common Stock | |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 6,600 | 28,415 (0%) | 0% | 0 | Common Stock | |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.22 per share. | 01 Oct 2021 | 92 | 23,527 (0%) | 0% | 15.2 | 1,400 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. | 01 Jul 2021 | 92 | 23,619 (0%) | 0% | 20.5 | 1,883 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.15 per share. | 08 May 2021 | 128 | 23,711 (0%) | 0% | 17.1 | 2,195 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. | 01 Apr 2021 | 92 | 23,839 (0%) | 0% | 24.3 | 2,234 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.04 per share. | 08 Feb 2021 | 148 | 23,931 (0%) | 0% | 36.0 | 5,334 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 18,000 | 18,000 | - | - | Option to Purchase Common Stock | |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 11,500 | 24,079 (0%) | 0% | 0 | Common Stock | |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.15 per share. | 08 Nov 2020 | 128 | 13,314 (0%) | 0% | 28.1 | 3,603 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. | 01 Oct 2020 | 92 | 13,442 (0%) | 0% | 42.1 | 3,871 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.75 per share. | 08 Aug 2020 | 128 | 13,534 (0%) | 0% | 48.8 | 6,240 | Common Stock |
Intercept Pharmaceuticals Inc | David A. Ford | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. | 01 Jul 2020 | 92 | 13,662 (0%) | 0% | 46.5 | 4,280 | Common Stock |